世界の血液銀行市場2021:免疫血液学・NAT製品の成長機会と戦略–アメリカ、ヨーロッパ、日本–サプライヤー売上高・シェア、規模・販売セグメント予測、競争分析、新技術、最新装置

◆英語タイトル:2021 Global Blood Banking Market: Growth Opportunities and Strategies for Immunohematology and NAT Products--US, Europe, Japan--Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation

Venture Planning Groupが発行した調査報告書(VPG21AG005)◆商品コード:VPG21AG005
◆発行会社(リサーチ会社):Venture Planning Group
◆発行日:2021年7月
◆ページ数:800
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Local PDFUSD27,500 ⇒換算¥4,015,000見積依頼/購入/質問フォーム
Global PDFUSD45,000 ⇒換算¥6,570,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

The report is available by geographic region, country, market segment, test category, section, and individual assay.

The report is available by section, and can be customized to specific information needs and budget.

This comprehensive seven- country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report explores future marketing and technological trends in the US, Europe and Japan; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Group Genotyping

PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing

Microarrays

BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, ; C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis

Sales and market share estimates for leading suppliers of blood typing, grouping and infectious disease screening tests by country and individual product.

Geographic Regions

Europe
France
Germany
Italy
Spain
UK

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales, M&A, product portfolios, marketing tactics, and new products in R&D.

Market Segmentation Analysis

- Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country.

- Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment:

     – Blood Centers
     – Plasma Fractionation Facilities
     – Hospitals
     – Commercial/Private Laboratories
     – Military Blood Banks

Current and Emerging Products

- Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays.

- Review of automated and semi-automated molecular and immunohematology analyzers.

strong>Technology Review

- Assessment of current and emerging technologies, and their potential applications for the blood banking market.

- Comprehensive lists of companies developing or marketing new technologies and products, by test.

Worldwide Market Overview

- Estimates of facilities performing blood banking tests, by country.

- Test volume and sales projections by country.

Strategic Recommendations

- New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation with significant market appeal.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Contains 775 pages and 227 tables

❖ レポートの目次 ❖

I. Introduction
II. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
III. Major Product Development Opportunities
A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
VI. Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious
Disease Screening Tests
1. Blood Typing and Grouping Tests
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. Infectious Disease Screening Tests
a. AIDS/HIV
- Background
- Diagnostic Tests
° Enzyme Immunoassay
° Viral Load/Drug Resistance Testing
° Genotype and Phenotype Testing
- Blood Banking Considerations
b. Hepatitis Markers
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D (Delta Hepatitis)
- Hepatitis E
- Hepatitis G
- Vaccines and Drugs
c. Cytomegalovirus
- Background
- Diagnostic Tests
- Vaccines and Drugs
d. Syphilis
- Background
- Diagnostic Tests
- Vaccines and Drugs
e. West Nile Virus
- Background
- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
f. Parvovirus B19
- Microbiology
- Epidemiology
- Clinical Syndromes
- Diagnostic Test
- Vaccines and Drugs
g. Creutzfeldt-Jakob’s Disease
- Background
- Transmission
- Diagnostic Tests
- Vaccines and Drugs
h. Malaria
i. Chagas Disease
j. Babesiosis
3. Pathogen Reduction
4. Leukocyte Reduction
- Background
- Methods
B. Instrumentation Review: Operating Characteristics,
Features and Selling Prices of Leading Blood Typing,
Grouping and Infectious Disease Screening Automated
and Semiautomated Analyzers
C. Major Blood Banking Technologies
and Their Potential Applications
1. Molecular Diagnostics
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
4. Microtitration Plates
5. IT and Automation
6. Lasers
7. Robotics
8. Synthetic Red Cell Substitutes
9. Genetically Engineered Blood Components
10. Blood Preservation
11. Autologous Blood Transfusion/Freezing
VII. France Blood Banking Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,
Major Supplier Sales and Market Shares
VIII. Germany Blood Banking Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,
Major Supplier Sales and Market Shares
IX. Italy Blood Banking Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,
Major Supplier Sales and Market Shares
X. Japan Blood Banking Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,
Major Supplier Sales and Market Shares
XI. Spain Blood Banking Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,
Major Supplier Sales and Market Shares
XII. U.K. Blood Banking Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,
Major Supplier Sales and Market Shares
XIII. U.S.A. Blood Banking Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,
Major Supplier Sales and Market Shares
XIV. Competitive Assessments
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio
Grifols
Hologic
Immucor
LabCorp
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Quidel
Roche
Siemens Healthineers
Tecan
Thermo Fisher

http://www.vpgcorp.com/webfiles/BLOOD%20BANKING/TOCLOT%202015%20Global%20Transfusion%20Diagnostics%20Market.pdf

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の血液銀行市場2021:免疫血液学・NAT製品の成長機会と戦略–アメリカ、ヨーロッパ、日本–サプライヤー売上高・シェア、規模・販売セグメント予測、競争分析、新技術、最新装置(2021 Global Blood Banking Market: Growth Opportunities and Strategies for Immunohematology and NAT Products--US, Europe, Japan--Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆